Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

Clinical trial NCT07614321 · RECRUITING

Trial details

NCT number: NCT07614321
Sponsor: Atlantic Health System
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis Lower Urinary Track Symptoms

Start date: 2026-04-01
Primary completion: 2028-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.